The Role of NIH in Drug Development Innovation and Its Impact on Patient Access
Proceedings of a Workshop
-
- USD 48.99
-
- USD 48.99
Descripción editorial
To explore the role of the National Institutes of Health (NIH) in innovative drug development and its impact on patient access, the Board on Health Care Services and the Board on Health Sciences Policy of the National Academies jointly hosted a public workshop on July 24–25, 2019, in Washington, DC. Workshop speakers and participants discussed the ways in which federal investments in biomedical research are translated into innovative therapies and considered approaches to ensure that the public has affordable access to the resulting new drugs. This publication summarizes the presentations and discussions from the workshop.
Más libros de National Academies of Sciences, Engineering, and Medicine
An Assessment of the National Institute of Standards and Technology Center for Neutron Research
2024
Low Birth Weight Babies and Disability
2024
Facial Recognition Technology
2024
Aging in Place with Dementia
2024
Supporting and Sustaining the Current and Future Workforce to Care for People with Serious Illness
2024
Developing an Agenda for Population Aging and Social Research in Low- and Middle-Income Countries (LMICs)
2024